根据多omics分析,表观遗传调节的ZCCHC9在质瘤中起着促进瘤的作用
Zhifeng Lin1, Jinghan Zhang2, Yufang Li3
1Sleep Medicine Center, Dalian Rehabilitation Recuperation Center of Joint Logistics Support Force of PLA, Dalian, Liaoning 116013, PR China; Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710038, PR China.
指CCHC域含有蛋白9 (ZCCHC9) 在质瘤中被上调,作为预后不良的生物标志物. 这种蛋白质通过免疫调节和治疗耐药性驱动质瘤的进展.
科学领域:
- 神经瘤学神经瘤学
- 癌症基因组学 癌症基因组学
- 分子瘤学分子瘤学
背景情况:
- 质瘤是一种具有挑战性的原发性脑瘤,死亡率高.
- 指CCHC域含蛋白9 (ZCCHC9) 在质瘤中的作用尚不清楚.
- 已知ZCCHC9在其他癌症 (如宫癌和非小细胞肺癌) 中也有作用.
研究的目的:
- 研究ZCCHC9在质瘤中的功能,机制和临床意义.
- 确定ZCCHC9作为潜在的诊断生物标志物和质瘤的治疗点.
主要方法:
- 使用TCGA,CGGA和HPA数据库进行多组分析.
- 卡普兰-梅尔,考克斯回归和ROC曲线分析用于预后和诊断价值.
- 在体外和体外功能实验验验证瘤作用.
主要成果:
- 在质瘤中发现了异常ZCCHC9上调,特别是在IV级和IDH野生类型亚型中.
- ZCCHC9作为一个独立的预后和诊断不良的生物标志物.
- ZCCHC9影响瘤的微环境,RNA的修饰,以及药物敏感性 (Temozolomide,Dabrafenib,Trametinib).
- 功能性研究证实ZCCHC9促进了繁殖和迁移,同时抑制了亡.
结论:
- ZCCHC9通过免疫调节,表观遗传失调和治疗耐药性驱动着质瘤的进展.
- ZCCHC9是一种有前途的诊断生物标志物,预后指标和质瘤的治疗点.
更多相关视频
09:45Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
相关概念视频
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Epigenetic Regulation
X-chromosome...
The Tumor Microenvironment
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
